Literature DB >> 1367381

Stimulation of proliferation and immunoglobulin production of human-human hybridoma by various types of caseins and their protease digests.

K Yamada1, I Ikeda, H Nakajima, S Shirahata, H Murakami.   

Abstract

We have studied the effect of such milk proteins as caseins, lactalbumin, and lactoglobulin, on proliferation and immunoglobulin production of human-human hybridoma HB4C5 cells. It was found that alpha-, beta-, and kappa-caseins stimulated both proliferation and IgM product ion of human-human hybridoma HB4C5 cells, while the activities of alpha-lactalbumin and beta-lactoglobulin were negligible. To localize the active sites of these caseins, effect of protease treatments on the activities were examined. When caseins were digested with trypsin, casein digests stimulated proliferation of the hybridoma, but not their IgM production. When kappa-casein was digested with chymosin and fractionated to p-kappa-casein and glycomacropeptide, both fragments stimulated proliferation of the cells, but only p-kappa-casein fragment stimulated IgM production. These results indicate that kappa-casein has at least two proliferation stimulating sites and an IgM production stimulating site in the p-kappa-casein region.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367381     DOI: 10.1007/bf00556298

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  17 in total

1.  Effect of immunoglobulin production stimulating factors in foodstuffs on immunoglobulin production of human lymphocytes.

Authors:  K Yamada; I Ikeda; M Maeda; S Shirahata; H Murakami
Journal:  Agric Biol Chem       Date:  1990-04

Review 2.  Human monoclonal antibody production. Current status and future prospects.

Authors:  K James; G T Bell
Journal:  J Immunol Methods       Date:  1987-06-26       Impact factor: 2.303

3.  [Primary structure of bovine kappa B casein. Complete sequence].

Authors:  J C Mercier; G Brignon; B Ribadeau-Dumas
Journal:  Eur J Biochem       Date:  1973-06

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component.

Authors:  H Murakami; H Masui; G H Sato; N Sueoka; T P Chow; T Kano-Sueoka
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

6.  Immunoglobulin production stimulating and inhibiting factors derived from human lung adenocarcinoma PC-8 cells : Ig production stimulating factor in PC-8 cells.

Authors:  H Shinmoto; H Murakami; K Yamada; S Dosako; H Omura
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

7.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10

8.  Partial purification and characterization of immunoglobulin production stimulating factor derived from Namalwa cells.

Authors:  K Yamada; K Akiyoshi; H Murakami; T Sugahara; I Ikeda; K Toyoda; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

9.  Purification and characterization of immunoglobulin production stimulating factor derived from human B lymphoblastoid HO-323 cells.

Authors:  K Toyoda; T Sugahara; K Inouye; K Yamada; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

10.  Stimulation of proliferation and immunoglobulin M production by lactoferrin in human-human and mouse-mouse hybridomas cultures in serum-free conditions.

Authors:  K Yamada; I Ikeda; T Sugahara; S Hashizume; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

View more
  1 in total

1.  Enhancement effects of BSA and linoleic acid on hybridoma cell growth and antibody production.

Authors:  M Kobayashi; S Kato; T Omasa; S Shioya; K Suga
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.